Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis

被引:5
|
作者
Fabiano, G. [1 ,2 ]
Marcellusi, A. [1 ,3 ]
Mennini, F. S. [1 ,3 ]
Sciattella, P. [3 ]
Favato, G. [1 ]
机构
[1] Kingston Univ, Inst Leadership & Management Hlth, London, England
[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[3] Univ Roma Tor Vergata, Fac Econ, Econ Evaluat & HTA EEHTA CEIS, Rome, Italy
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2023年 / 24卷 / 01期
关键词
Human papillomavirus; Real world; Resource utilization; Hospital episodes statistics; England; GENITAL WARTS; CERVICAL-CANCER; BURDEN; MEN; PREVALENCE; CARE;
D O I
10.1007/s10198-022-01453-x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and objective HPV (human papillomavirus) is the virus most often responsible for sexually transmitted infections. The burden of HPV-related diseases on hospital resources represents a major public health problem. The objective of this study was to quantify the lifetime economic burden of HPV-related diseases based on hospital resources from the perspective of National Health Service (NHS) in England. Methods Patients' data were extracted, anonymised and aggregated by NHS digital from Hospital Episode Statistics (HES) database of patients admitted in 2015 and followed for three years. Data on hospitalizations were identified according to the International Classification of Diseases (ICD-10 CM). Health Resource Group (HRG) tariffs and National Reference Costs were used to estimate the hospitalization costs of anal, cervical, genital, oropharyngeal cancers as well as anogenital warts and cervical dysplasia. Results A total of 19,296 hospitalized patients were included in the estimation model, (39% was male and 61% female. At admission, the average age was 60 and 50 years old, respectively). Life-time costs per patients diagnosed with oropharyngeal cancer were 16,911 pound (17,142 pound for male and 16,334 pound for female), penile cancer 12,539 pound, vaginal cancer 12,676 pound, anal cancer 13.773 pound (12,590 pound for male, 14,525 pound for female). Cervical cancer accounted for 12,721 pound, whereas cervical dysplasia for 3932 pound. Resource used for hospitalized patients with anogenital warts was equal to 872 pound (884 pound and 856 pound for men and women, respectively). On average, outpatient accounted for 39% of the total lifetime costs. Conclusion The results of this study highlight that a substantial amount of resources is utilized for the treatment of HPV-related diseases at hospital level in England. These measures have the potential to inform policy decisions to ensure an optimal use of the NHS resources.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 50 条
  • [1] Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
    G. Fabiano
    A. Marcellusi
    F. S. Mennini
    P. Sciattella
    G. Favato
    The European Journal of Health Economics, 2023, 24 : 75 - 80
  • [2] Economic burden of HPV9-related diseases: a real-world cost analysis from Italy
    F. S. Mennini
    Gianluca Fabiano
    G. Favato
    P. Sciattella
    P. Bonanni
    C. Pinto
    A. Marcellusi
    The European Journal of Health Economics, 2019, 20 : 829 - 840
  • [3] Economic burden of HPV9-related diseases: a real-world cost analysis from Italy
    Mennini, F. S.
    Fabiano, Gianluca
    Favato, G.
    Sciattella, P.
    Bonanni, P.
    Pinto, C.
    Marcellusi, A.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2019, 20 (06): : 829 - 840
  • [4] RESOURCE UTILISATION AND BLEEDING EVENTS DURING ANTICOAGULATION TREATMENT: REAL-WORLD FINDINGS FROM ENGLAND
    Lister, S.
    Lefevre, C.
    Menown, I
    Alikhan, R.
    Lacoin, L.
    Bird, A.
    You, M.
    Ridha, E.
    Evans, D.
    VALUE IN HEALTH, 2015, 18 (07) : A396 - A397
  • [5] The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity
    Orumaa, Madleen
    Kjaer, Susanne K.
    Dehlendorff, Christian
    Munk, Christian
    Olsen, Anne Olaug
    Hansen, Bo T.
    Campbell, Suzanne
    Nygard, Mari
    VACCINE, 2020, 38 (06) : 1345 - 1351
  • [6] ESTIMATION OF THE HEALTH AND COST BURDEN OF HPV-RELATED DISEASES IN THAILAND
    Termrungruanglert, W.
    Havanond, P.
    Khemapech, N.
    Lertmaharit, S.
    Pongpanich, S.
    Khorprasert, C.
    Kitsiripornchai, S.
    Jirakorbchaipong, P.
    Taneepanichskul, S.
    VALUE IN HEALTH, 2010, 13 (07) : A511 - A512
  • [7] HOSPITALIZATION COST AND LENGTH OF STAY ASSOCIATED WITH HPV-RELATED DISEASES
    Tsakeu, E.
    Petit, C.
    Chevalier, P.
    VALUE IN HEALTH, 2016, 19 (07) : A611 - A611
  • [8] ESTIMATING THE COST OF HPV-RELATED DISEASES IN TURKEY: A DELPHI APPROACH
    Bakir, M.
    Ayhan, A.
    Arvas, M.
    Kose, M. F.
    Gungor, M.
    Ortac, F.
    Ozgul, N.
    Yuce, K.
    Ergun, T.
    Gungor, E.
    Altundag, O.
    Saka, G.
    VALUE IN HEALTH, 2013, 16 (07) : A404 - A405
  • [9] THE BROADER BURDEN OF HPV-RELATED DISEASE IN ENGLAND: A PRELIMINARY ANALYSIS
    Khalid, J. M.
    Amelio, J. M.
    Carroll, S. M.
    Charman, F.
    Maguire, A.
    VALUE IN HEALTH, 2011, 14 (07) : A437 - A437
  • [10] Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost
    Singer, David
    Thompson-Leduc, Philippe
    Ma, Siyu
    Gupta, Deepshekhar
    Cheng, Wendy Y.
    Muthukumar, Aruna
    Devine, Francesca
    Sundar, Manasvi
    Bogart, Michael
    Hagopian, Ella
    Poston, Sara
    Duh, Mei Sheng
    Oppenheimer, John J.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)